<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>TXA administration (trauma) - Procedures - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>TXA</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../procedures.html">Back to Procedures</a>
        <a class="btn small" href="../procedures_menu.html">Back to Procedures Menu</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Circulation / Hemorrhage Procedure</div>
      <h1>TXA administration (trauma)</h1>

      <div class="content">
        <h3>Indications</h3>
        <ul>
          <li>Suspected or confirmed major hemorrhage due to trauma where hyperfibrinolysis is a concern, especially if:
            <ul>
              <li>Hemorrhagic shock or ongoing significant bleeding, OR</li>
              <li>High risk of significant bleeding based on mechanism/injuries</li>
            </ul>
          </li>
          <li>Time-sensitive: benefit is greatest when given early after injury (VERIFY your local time window; commonly "as soon as possible" and within hours)</li>
        </ul>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Use per local protocol and medical direction</li>
          <li>Known hypersensitivity to TXA</li>
          <li>Caution / risk-benefit considerations (VERIFY local protocol):
            <ul>
              <li>Active intravascular clotting / recent thromboembolic event history</li>
              <li>Isolated head injury without systemic bleeding (protocol-dependent)</li>
              <li>Significant renal impairment (dose considerations in some contexts)</li>
            </ul>
          </li>
          <li>Do not delay definitive hemorrhage control/resuscitation to administer TXA</li>
        </ul>

        <h3>Equipment</h3>
        <ul>
          <li>TXA vial/ampoule per your stock concentration</li>
          <li>IV/IO access + flush</li>
          <li>Syringes/needles, minibag or syringe pump setup as per local practice</li>
          <li>Labeling and documentation supplies</li>
          <li>Monitoring: ECG, BP, SpO2</li>
        </ul>

        <h3>Steps (checklist)</h3>
        <ol>
          <li><strong>Identify candidate early</strong>
            <ul>
              <li>Trauma + suspected significant bleeding / hemorrhagic shock risk</li>
              <li>Start as early as possible once criteria met (do not wait for labs)</li>
            </ul>
          </li>
          <li><strong>Administer TXA per local protocol (VERIFY)</strong>
            <ul>
              <li>Common trauma regimen used in many systems (VERIFY):
                <ul>
                  <li>1 g IV over ~10 minutes, then 1 g infusion over ~8 hours</li>
                  <li>Some systems use a 2 g IV bolus approach (protocol-dependent)</li>
                </ul>
              </li>
              <li>Route:
                <ul>
                  <li>IV preferred; IO acceptable if IV not available (follow local guidance)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Continue hemorrhage management in parallel</strong>
            <ul>
              <li>Control bleeding (tourniquet, packing, pressure dressings)</li>
              <li>Resuscitation per protocol (fluids/blood products availability varies)</li>
              <li>Prevent hypothermia; monitor for deterioration</li>
            </ul>
          </li>
        </ol>

        <h3>Confirmation / success criteria</h3>
        <ul>
          <li>TXA delivered without adverse reaction</li>
          <li>Ongoing reassessment of hemorrhage/shock response occurs (TXA is adjunctive; not a "response marker" itself)</li>
        </ul>

        <h3>Complications + immediate management</h3>
        <ul>
          <li><strong>Hypersensitivity reaction (rare)</strong>
            <ul>
              <li>Stop administration; treat per anaphylaxis protocol if indicated</li>
            </ul>
          </li>
          <li><strong>IV site irritation / infusion issues</strong>
            <ul>
              <li>Check patency, slow/adjust administration per protocol</li>
            </ul>
          </li>
          <li><strong>Thromboembolic risk (contextual/rare in acute dosing; monitor clinically)</strong>
            <ul>
              <li>Maintain vigilance; follow local reporting/escalation pathways</li>
            </ul>
          </li>
        </ul>

        <h3>Aftercare / monitoring</h3>
        <ul>
          <li>Document:
            <ul>
              <li>Indication, time from injury (estimate), time given, dose/regimen, route (IV/IO), adverse events</li>
            </ul>
          </li>
          <li>Ensure handover includes:
            <ul>
              <li>TXA given, regimen started/completed, and remaining infusion needs (if applicable)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Canadian journal summary (dose/time concepts)
            <ul>
              <li><a href="https://www.cmaj.ca/content/186/15/e587" target="_blank" rel="noopener">CMAJ — Tranexamic acid for trauma-related hemorrhage</a></li>
            </ul>
          </li>
          <li>Canadian health authority guideline (massive hemorrhage; includes TXA discussion)
            <ul>
              <li><a href="http://www.phsa.ca/Documents/Trauma-Services/2024-04-10_Massive_Hemorrhage.pdf" target="_blank" rel="noopener">PHSA (BC) Massive Hemorrhage guideline (PDF)</a></li>
            </ul>
          </li>
          <li>Canadian trauma education slide set (TXA overview)
            <ul>
              <li><a href="https://www.traumacanada.org/wp-content/uploads/2017/10/TXA-in-Trauma-Beno.pdf" target="_blank" rel="noopener">Trauma Canada — TXA in Trauma (PDF)</a></li>
            </ul>
          </li>
        </ul>
      </div>
    </section>
  </main>
</body>
</html>
